Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.061%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR / Director Dealings

4 Feb 2020 15:20

RNS Number : 9528B
Mercia Asset Management PLC
04 February 2020
 

RNS

4 February 2020

 

Mercia Asset Management PLC

("Mercia", the "Group" or the "Company")

PDMR / Director Dealings

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager, announces that it has received a notification of the following transactions relating to Ordinary shares of £0.00001 each in the capital of Mercia ("Ordinary Shares") by a Director.

For tax planning purposes Ray Chamberlain, a Non-executive Director of the Company, sold 6,149,752 Ordinary Shares at 26.6p per share, all of which were bought by Forward Nominees Limited (as nominee for certain members of the Chamberlain family and close associates (including Ray Chamberlain)) (the "Transactions").

Following the Transactions Ray Chamberlain will cease to be personally interested in any Ordinary Shares but will continue to be indirectly interested in 64,824,766 Ordinary Shares via:

·; Forward Innovation Fund (38,072,336 Ordinary Shares);

·; Croftdawn Limited (3,994,786 Ordinary Shares);

·; Mercia Growth Nominees Limited (126,436 Ordinary Shares);

·; Forward Nominees Limited (as nominee for certain members of the Chamberlain family and close associates (including Ray Chamberlain)) (22,631,208 Ordinary Shares).

In aggregate, the total number of Ordinary Shares in which Ray Chamberlain is interested remains unchanged, representing 14.73% of the Company's issued Ordinary Share capital.

The notifications below are made in accordance with the requirements of the Market Abuse Regulations.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ray Chamberlain

2

Reason for the notification

a)

Position / status

Director (PDMR)

b)

Initial notification / amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

LEI

213800A1Q4CF57NECG66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.00001 each

ISIN: GB00BSL71W47

b)

 

Nature of the transaction

 

Sale of 6,149,752 Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

26.6p per share

6,149,752

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - single transaction 

e)

Date of the transaction

4 February 2020

f)

Place of the transaction

AIM (AIMX)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ray Chamberlain

2

Reason for the notification

a)

Position / status

Director (PDMR)

b)

Initial notification / amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

LEI

213800A1Q4CF57NECG66

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.00001 each

ISIN: GB00BSL71W47

b)

 

Nature of the transaction

 

Purchase of 6,149,752 Ordinary Shares by Forward Nominees Limited (as nominee for certain members of the Chamberlain family (including Ray Chamberlain))

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

26.6p per share

6,149,752

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - single transaction 

e)

Date of the transaction

4 February 2020

f)

Place of the transaction

AIM (AIMX)

 

For further information, please contact:

Mercia Asset Management PLC

+44 (0)330 223 1430

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Richard Andrews

N+1 Singer (Joint Broker)

Harry Gooden James Moat

+44 (0)20 7496 3000

Buchanan Communications

+44 (0)20 7466 5000

Chris Lane, Vicky Hayns, Stephanie Watson

www.buchanan.uk.com

 

About Mercia Asset Management PLC:

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital; the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

The Group has a strong UK regional footprint through its eight offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia has c.£775million of assets under management and, since its IPO in December 2014, has invested over £90million across its direct investment portfolio.

Mercia Asset Management PLC is quoted on AIM with the epic "MERC".

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEZLFBBLLFBBZ
Date   Source Headline
5th Jan 20227:00 amRNSCompletion of the sale of Faradion
31st Dec 20217:00 amRNSSale of Faradion Limited
22nd Dec 20217:00 amRNSFurther direct investment into Intechnica Group
7th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSSoccer Manager secures significant new licences
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.